Chordia Therapeutics Inc.

¥42.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:190AHealthcare
Country Japan
PE (Fwd) •••
TSR 2Y CAGR (45.01%)
Div yield —
ROE (66.71%)
Biotechnology
Beta (5Y) 3.21
PE TTM —
TSR TTM (62.16%)
Mkt cap ¥3.249B
ROIC (42.23%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥54
29.73%
(55.98%)
Hold 5|4|10|8|5
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
0.47
0.45
0.43
0.43
22.05%
15.91%
3.54%
0.04%
Revenue¥M
139.4
139.8
138.0
134.2
2.97%
(1.26%)
(2.66%)
(5.50%)
Peers (US$20.63M)
Cap (US$)
PE
20.83M
99.41x
20.20M
—
20.68M
—
Capital
TTM
5Y
10Y
Leveragex
3.106
0.326
0.277
EBIT/Intx
2.560
0.659
0.561
Own earn%
72.78
(38.78)
(24.24)
Sh yield%
14.09
33.18
33.37
Owners
Insiders/Inst%
2.97
48.76
Short interest%
3.40
SBC / revenue%
4.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
7